These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 6370487

  • 1. Immunization against leprosy: progress and prospects.
    Noordeen SK, Sansarricq H.
    Bull World Health Organ; 1984; 62(1):1-6. PubMed ID: 6370487
    [Abstract] [Full Text] [Related]

  • 2. Immunization against leprosy: progress and prospects.
    Noordeen SK, Sansarricq H.
    Bull Pan Am Health Organ; 1984; 18(3):295-99. PubMed ID: 6509251
    [Abstract] [Full Text] [Related]

  • 3. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [Abstract] [Full Text] [Related]

  • 4. Rationales for vaccines against leprosy.
    Bloom BR.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract] [Full Text] [Related]

  • 5. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
    Convit J, Aranzazu N, Pinardi M, Ulrich M.
    Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
    [Abstract] [Full Text] [Related]

  • 6. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract] [Full Text] [Related]

  • 7. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
    Convit J, Aranzazu N, Ulrich M, Pinardi ME, Reyes O, Alvarado J.
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM, Convit J, Ulrich M, Gallinotto ME, Aranzazu N.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [Abstract] [Full Text] [Related]

  • 9. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG.
    Indian J Lepr; 1984 Dec; 56(4):764-75. PubMed ID: 6442720
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy and immunoprophylaxis of leprosy.
    Convit J, Ulrich M.
    Indian J Lepr; 2000 Dec; 72(1):21-32. PubMed ID: 10935184
    [No Abstract] [Full Text] [Related]

  • 11. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD, Anantharaman DS, De Britto RL, Vallishayee RS, Nagaraju B, Kannan S, Sengupta U.
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [Abstract] [Full Text] [Related]

  • 12. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ, Meyers WM.
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [Abstract] [Full Text] [Related]

  • 13. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Martin LN, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [Abstract] [Full Text] [Related]

  • 14. Investigations related to the development of a leprosy vaccine.
    Convit J, Aranzazu N, Ulrich M, Zúñiga M, de Aragón ME, Alvarado J, Reyes O.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):531-9. PubMed ID: 6231259
    [No Abstract] [Full Text] [Related]

  • 15. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
    Ponnighaus JM, Fine PE.
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaccination and skin test studies on the children of leprosy patients.
    Stanford JL, Stanford CA, Ghazi Saidi K, Dowlati Y, Weiss SF, Farshchi Y, Madlener F, Rees RJ.
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
    [Abstract] [Full Text] [Related]

  • 18. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH, Rees RH, Liew FY.
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [Abstract] [Full Text] [Related]

  • 19. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K, Stanford JL, Stanford CA, Dowlati Y, Farshchi Y, Rook GA, Rees RJ.
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [Abstract] [Full Text] [Related]

  • 20. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.
    Gill HK, Mustafa AS, Godal T.
    Bull World Health Organ; 1986 Mar; 64(1):121-6. PubMed ID: 3524883
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.